LAUSR

Trigeminal schwannomas are benign slow-growing tumors originating from the peripheral nerve sheath. They account for 0.1%–0.4% of all intracranial tumors and 1%–8% of all intracranial schwannomas. 1 , 2 , 3 While most of these tumors develop in the trigeminal ganglion within the middle fossa, trigeminal schwannomas can develop anywhere along the course of the trigeminal nerve. As a result, they can be intradural, interdural, and extradural. 4 , 5 Trigeminal schwannomas from the pterygopalatine fossa (PPF) are extremely rare and very difficult to remove because of limited access to this region and the rich neurovascular contents. Numerous traditional microsurgical approaches to the PPF have been described; however, they are more invasive with increased morbidity. 6 , 7 Therefore, endoscopic endonasal surgery is a feasible solution. This technique allows good visualization of the region with decreased morbidity and a shorter recovery period. A previously healthy, 40-year-old woman presented with right facial pain for 3 weeks. On neurologic examination, the patient had hypoesthesia in the territory of the maxillary (V2) branch of the right trigeminal nerve. She had no other symptoms on physical examination. Cranial computed tomography and magnetic resonance imaging were performed and showed a high signal density mass in the right PPF that exhibited heterogeneous contrast enhancement. She was initially treated with low-dose carbamazepine; however, the dose could not be further increased because of drowsiness and dizziness. Given the size and location of the mass, an endoscopic endonasal approach was performed, and the tumor was successfully resected ( Video 1 ). The postoperative course was uneventful, and the patient had significant improvement of her symptoms and was discharged with no new neurologic deficits. However, she continued to have hypoesthesia of the V2 segment of the trigeminal nerve.